Cardiac Safety Network

Cardiac Safety Network (CSN) is a contract research organization (CRO) specializing in centralized cardiac safety services for the pharmaceutical and biotechnology industries. The company provides comprehensive ECG, Holter monitoring, and ambulatory blood pressure monitoring (ABPM) services to support clinical trials, ensuring regulatory compliance with Thorough QT (TQT) study requirements. CSN's expertise lies in the collection, analysis, and interpretation of cardiac data to assess the proarrhythmic potential of new drug candidates. In April 2013, the company was acquired by BioTelemetry, Inc., which was later acquired by Royal Philips in 2021. CSN's operations were integrated into BioTelemetry's clinical research division to enhance its cardiac monitoring capabilities.